Ino Therapeutics Llc Headquarters
Looking for information about Ino Therapeutics Llc Headquarters? The links below have collected all the necessary data.
https://www.bloomberg.com/profile/company/0155230Z:US
INO Therapeutics LLC provides medical products. The Company offers surgical appliance, ventilator, monograph, and alarm safety products, as well emergency and support services.Employees: 99
https://www.crunchbase.com/organization/ino-therapeutics
Biotechnology. Pharmaceutical. Headquarters Regions Greater New York Area, East Coast, Northeastern US. Founded Date 1998. Operating Status Active. Company Type For Profit. Contact Email [email protected]. Phone Number 9082386773.Founded: 1998
https://www.bloomberg.com/profile/company/911548Z:US
INO Therapeutics, Inc. produces and distributes pharmaceutical products. The Company offers critical care, therapies, and hypoxic respiratory failure treatment for newborns.
https://www.corporationwiki.com/Ohio/Independence/ino-therapeutics-llc-3577275.aspx
Ino Therapeutics LLC Overview. Ino Therapeutics LLC filed as a Foreign Limited Liability in the State of Florida on Tuesday, December 16, 2003 and is approximately eighteen years old, according to public records filed with Florida Department of State.A corporate filing is called a foreign filing when an existing corporate entity files in a state other than the state they originally filed in.
https://www.manta.com/c/mmjwmh7/ino-therapeutics-llc
Get information, directions, products, services, phone numbers, and reviews on Ino Therapeutics in Bedminster, undefined Discover more Pharmaceutical Preparations companies in Bedminster on Manta.com Ino Therapeutics Bedminster NJ, 07921 – Manta.comEmployees: 99
https://www.bizapedia.com/or/ino-therapeutics-llc.html
Ino Therapeutics LLC is an Oregon Foreign Limited-Liability Company filed On January 12, 2004. The company's filing status is listed as Active and its File Number is 195034-99. The Registered Agent on file for this company is C T Corporation System and is located at …Location: MO
INOVIO Receives Authorization to Conduct Phase 3 Efficacy Trial of its COVID-19 DNA Vaccine Candidate, INO-4800. August 9, 2021 INOVIO Reports Second Quarter 2021 Financial Results. August 9, 2021 INOVIO and Advaccine Receive Regulatory Allowance for Two Heterologous Prime-Boost Clinical Trials in China Using INO-4800, INOVIO’s COVID-19 DNA ...
https://www.inovio.com/contact-us/
Corporate Headquarters. 660 W. Germantown Pike, Suite 110 Plymouth Meeting, PA 19462 Phone: 267-440-4200 Fax: 267-440-4242
https://www.fiercebiotech.com/biotech/press-release-ikaria-and-investor-group-to-acquire-ino-therapeutics-670-million
Feb 22, 2007 · Ikaria and Investor Group to Acquire INO Therapeutics in $670 Million Cash and Stock Merger, Creating a World Leader in Critical Care Therapeutics Combined Company Will Have More Than $160 Million ...
https://www.mallinckrodt.com/contact-us
For more information about careers at Mallinckrodt Pharmaceuticals, please visit our Careers website. Compliance & Business Integrity. Compliance Department. 908.238.6600. [email protected]. For the ability to report concerns about Mallinckrodt's business practices, please feel free to contact our Integrity Hotline at (888) 696-9864.
Have you found Ino Therapeutics Llc Headquarters information?
On our site you can find many other information about headquarters of any company. Research information about other companies.
Related Pages:
|
Recently Added Pages:
|